Publications by authors named "Michael Carducci"

Claim this Profile
N
National Cancer Institute's Working Group on Biochemically Recurrent Prostate Cancer: Clinical Trial Design Considerations.
David J Einstein, Melissa L Abel, Jeanny B Aragon-Ching, Philip M Arlen, Karen A Autio, Michael A Carducci

J Clin Oncol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Scrambler therapy for chemotherapy-induced peripheral neuropathy: A case report.
Zhu Wang, Michael Carducci, Giuseppe Marineo, Thomas Smith

Palliat Support Care· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluating the Impact of Weekly Physical Performance Reports on Daily Physical Activity and Symptoms Among Cancer Survivors: Secondary Analysis of a Randomized Controlled Trial.
Mingfang Li, Chitchanok Benjasirisan, Jingyu Zhang, Jennifer Yeong-Shin Sheng, Junxin Li, Michael Carducci

Cancers (Basel)· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Systemic Therapy in Patients With Metastatic Castration-Resistant Prostate Cancer: ASCO Guideline Update.
Rohan Garje, Irbaz Bin Riaz, Syed Arsalan Ahmed Naqvi, R Bryan Rumble, Mary-Ellen Taplin, Michael A Carducci

J Clin Oncol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Comparison of In-Person and Telehealth Personalized Exercise Programs for Cancer Survivors: A Secondary Data Analysis.
Nada Lukkahatai, Gyumin Han, Chitchanok Benjasirisan, Jongmin Park, Hejingzi Monica Jia, Michael Carducci

Cancers (Basel)· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Digital Pathology-based Artificial Intelligence Biomarker Validation in Metastatic Prostate Cancer.
Mark C Markowski, Yi Ren, Meghan Tierney, Trevor J Royce, Rikiya Yamashita, Michael A Carducci

Eur Urol Oncol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes of Radium-223 and Stereotactic Ablative Radiotherapy Versus Stereotactic Ablative Radiotherapy for Oligometastatic Prostate Cancers: The RAVENS Phase II Randomized Trial.
Jarey H Wang, Alexander D Sherry, Soha Bazyar, Philip Sutera, Noura Radwan, Michael A Carducci

J Clin Oncol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genetic Drivers of Quality of Life in Prostate Cancer: An Evaluation of Genetic Polymorphisms and Patient-reported Outcomes in the E3805 CHAARTED trial.
Daniel Sentana-Lledo, Xiangying Chu, Charles J Ryan, Arjun Gupta, Christopher J Sweeney, Michael A Carducci

Eur Urol Oncol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inferred clonal hematopoiesis from tumor DNA sequencing among men with prostate cancer: correlation with somatic tumor alterations and outcomes.
Yasaman Iranmanesh, Noha Omar, Arya Rasouli, Alex Baras, Sergiu Pasca, Michael A Carducci

Oncologist· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of SGLT2 Inhibitor Initiation and PSA Response in Prostate Cancer.
Etan R Aber, Michael A Carducci, Channing J Paller, Sam R Denmeade, Kelli Rourke

Prostate· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient-reported Quality of Life and Survival Outcomes in Prostate Cancer: Analysis of the ECOG-ACRIN E3805 Chemohormonal Androgen Ablation Randomized Trial (CHAARTED).
Daniel Sentana-Lledo, Xiangying Chu, David F Jarrard, Michael A Carducci, Robert S DiPaola

Eur Urol Oncol· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase 1 study of the combination of BH3-mimetic, navitoclax, and mTORC1/2 inhibitor, vistusertib, in patients with advanced solid tumors.
Susan C Scott, Anna Farago, W Victoria Lai, Marianna Zahurak, Michelle A Rudek, Michael A Carducci

Cancer Chemother Pharmacol· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Implementing evidence-based strategies for men with biochemically recurrent and advanced prostate cancer: Consensus recommendations from the US Prostate Cancer Conference 2024.
Alan H Bryce, Neeraj Agarwal, Himisha Beltran, Maha H Hussain, Oliver Sartor, Michael A Carducci

Cancer· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CRM1 regulates androgen receptor stability and impacts DNA repair pathways in prostate cancer, independent of the androgen receptor.
Rajendra Kumar, Janet Mendonca, Abhishek Shetty, Yuhan Yang, Olutosin Owoyemi, Michael A Carducci

FASEB J· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Initial Experience with [Lu]Lu-PSMA-617 After Regulatory Approval for Metastatic Castration-Resistant Prostate Cancer: Efficacy, Safety, and Outcome Prediction.
Andrei Gafita, Andrew Voter, Somya Shesadri, Avery Spitz, Catherine H Marshall, Michael A Carducci

J Nucl Med· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and Toxicity of [Lu]Lu-PSMA-617 for Metastatic Castration-Resistant Prostate Cancer: Results from the U.S. Expanded-Access Program and Comparisons with Phase 3 VISION Data.
Vishnu Murthy, Andrew F Voter, Kathleen Nguyen, Martin Allen-Auerbach, Lucia Chen, Michael A Carducci

J Nucl Med· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Olaparib Without Androgen Deprivation for High-Risk Biochemically Recurrent Prostate Cancer Following Prostatectomy: A Nonrandomized Controlled Trial.
Catherine H Marshall, Benjamin A Teply, Jiayun Lu, Lia Oliveira, Hao Wang, Michael A Carducci

JAMA Oncol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: Behavioral Weight Loss Programs for Cancer Survivors Throughout Maryland: Protocol for a Pragmatic Trial and Participant Characteristics.
Gerald J Jerome, Lawrence J Appel, Linda Bunyard, Arlene T Dalcin, Nowella Durkin, Michael A Carducci

JMIR Res Protoc· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reply to J.A. Garcia et al.
Susan Halabi, Siyuan Guo, Akash Roy, Larysa E Rydzewska, Peter Godolphin, Michael A Carducci

J Clin Oncol· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Perioperative nivolumab versus observation in patients with renal cell carcinoma undergoing nephrectomy (PROSPER ECOG-ACRIN EA8143): an open-label, randomised, phase 3 study.
Mohamad E Allaf, Se-Eun Kim, Viraj Master, David F McDermott, Lauren C Harshman, Michael A Carducci

Lancet Oncol· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High-Dose Intravenous Vitamin C Combined with Docetaxel in Men with Metastatic Castration-Resistant Prostate Cancer: A Randomized Placebo-Controlled Phase II Trial.
Channing J Paller, Marianna L Zahurak, Adel Mandl, Nicole A Metri, Aliya Lalji, Michael A Carducci

Cancer Res Commun· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of structural, biochemical, pharmacokinetic, and pharmacodynamic properties of the LSD1 inhibitor bomedemstat in preclinical models.
Sumer Jasmine, Adel Mandl, Timothy E G Krueger, Susan L Dalrymple, Lizamma Antony, Michael A Carducci

Prostate· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Behavioral Weight Loss Programs for Cancer Survivors Throughout Maryland: Protocol for a Pragmatic Trial and Participant Characteristics.
Gerald J Jerome, Lawrence J Appel, Linda Bunyard, Arlene T Dalcin, Nowella Durkin, Michael A Carducci

JMIR Res Protoc· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expert Perspectives on Controversies in Castration-Sensitive Prostate Cancer Management: Narrative Review and Report of the First US Prostate Cancer Conference Part 1.
E David Crawford, Alan H Bryce, Maha H Hussain, Neeraj Agarwal, Himisha Beltran, Michael A Carducci

JU Open Plus· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expert Perspectives on Controversies in Metastatic Castration-Resistant Prostate Cancer Management: Narrative Review and Report of the First US Prostate Cancer Conference Part 2.
Alan H Bryce, E David Crawford, Neeraj Agarwal, Maha H Hussain, Himisha Beltran, Michael A Carducci

JU Open Plus· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis